Table 1 Baseline characteristics of the subjects enrolled in the present study
From: Hepatitis B virus inhibits the in vivo and in vitro synthesis and secretion of apolipoprotein C3
Clinical parameters | Healthy individuals (n = 102) | HBV patients (n = 149) | P |
|---|---|---|---|
Age (years) | 43.1 ± 11.5 | 44.7 ± 12.5 | 0.437 |
Gender (male/female) | 70/32 | 105/44 | 0.397 |
BMI | 24.7 ± 1.4 | 25.3 ± 1.6 | 0.485 |
ALT(IU/l) | <30 | 215.2 ± 262.5 | <0.01 |
AST(IU/l) | <30 | 139.5 ± 182.4 | <0.01 |
TC (mmol/L) | 4.28 ± 0.58 | 3.86 ± 0.75 | <0.01 |
HDL-C(mmol/L) | 1.62 ± 0.27 | 1.38 ± 0.32 | <0.01 |
LDL-C (mmol/L) | 2.63 ± 0.56 | 2.25 ± 0.55 | <0.01 |
ApoA1(g/mL) | 1.38 ± 0.16 | 0.93 ± 0.27 | <0.01 |
ApoB(g/mL) | 0.88 ± 0.24 | 0.73 ± 0.18 | <0.01 |